Article
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
The Journal of allergy and clinical immunology - 1 Nov 2009
Philip George, van Adelsberg Janet, Loeys Thomas, Liu Nancy, Wong Peggy, Lai Eseng, Dass S Balachandra, Reiss Theodore F
Abstract excerpt
BACKGROUND: Prostaglandin D(2) is a proinflammatory mediator believed to be important in asthma and allergic rhinitis (AR). Allelic variants in the prostaglandin D(2) receptor type 1 (DP1) gene (PTGDR) have been suggested to be associated with asthma susceptibility. OBJECTIVES: We sought to investigate the efficacy of the DP1 antagonist laropiprant (alone or with montelukast) in asthma and seasonal AR and explore...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
